| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 08/27/2002 | US6439577 Rotating seals for cell processing systems |
| 08/22/2002 | WO2002064827A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | WO2002064757A2 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/22/2002 | WO2002064755A2 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | WO2002064748A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | WO2002064625A1 Matrix gene expression in chondrogenesis |
| 08/22/2002 | WO2002064157A2 Localized myocardial injection method for treating ischemic myocardium |
| 08/22/2002 | WO2002064152A1 Cardiomyocytes and methods of culture of same |
| 08/22/2002 | WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 08/22/2002 | WO2002064104A1 Methods for treating fingernails and toenails |
| 08/22/2002 | WO2002064065A2 Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
| 08/22/2002 | WO2002064063A1 Bioartificial device for storing, cultivating and/or reproducing cells |
| 08/22/2002 | WO2002064057A2 Use of cell penetrating peptides to generate antitumor immunity |
| 08/22/2002 | WO2002064026A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno |
| 08/22/2002 | WO2002064014A2 Endomural therapy |
| 08/22/2002 | WO2002063962A1 Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| 08/22/2002 | WO2002063938A2 Production and use of dopaminergic cells to treat dopaminergic deficiencies |
| 08/22/2002 | WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2002036170A3 Vector system for transducing the positive neurons |
| 08/22/2002 | WO2002011549A3 Treatment of mycobacterial infection |
| 08/22/2002 | WO2002000233A3 Purging of cells using viruses |
| 08/22/2002 | WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2001072295A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2000033865A9 Methods of inhibiting ectopic calcification |
| 08/22/2002 | WO2000032112A9 Embolization device |
| 08/22/2002 | US20020116724 Nucleotide sequences codingolypeptide for use in the diagnosis and prevention of psoriasis and venous ulcers |
| 08/22/2002 | US20020116069 Injectable implants for tissue augmentation and restoration |
| 08/22/2002 | US20020115647 Use of adipose tissue-derived stromal cells for chondrocyte differentiation and cartilage repair |
| 08/22/2002 | US20020115597 Antibiotics GE 23077, pharmaceutically acceptable salts and compositions, and use thereof |
| 08/22/2002 | US20020115585 Method and devices for the removal of psoralens from blood products |
| 08/22/2002 | US20020115214 Induction of lymphocytes; obtain cells, activate cells, incubate with activator, monitor lymphocyte proliferation |
| 08/22/2002 | US20020115213 Engraftable neural progenitor & stem cells for brain tumor therapy |
| 08/22/2002 | US20020115190 Culture of staphylococcus aureus and a method for preparing the same |
| 08/22/2002 | US20020115156 Connective tissue growth factor for use in the treatment of cancer, fibrotic defects and atherosclerosis; for use as wound healing agents |
| 08/22/2002 | US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects |
| 08/22/2002 | US20020115118 Multi-functional reagent for erythrocytes |
| 08/22/2002 | US20020115064 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease |
| 08/22/2002 | US20020114846 For protecting against effects of Tumor Necrosis Factor (TNF); for protecting cardiomyocytes in a cell; for producing inhibitory A2-phospholipase activity; for normalizing biochemical parameters of liver function |
| 08/22/2002 | US20020114845 Methods for processing animal tissues |
| 08/22/2002 | US20020114841 Composition and method |
| 08/22/2002 | US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 08/22/2002 | US20020114812 Preparing cells as cancer therapy for administration to a subject with cancer comprising culturing cells in the presence of an macrophage migration inhibitory factor antagonist |
| 08/22/2002 | US20020114794 Staphylococcus aureus culture and preparation thereof |
| 08/22/2002 | US20020114793 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 08/22/2002 | US20020114792 Alpha-2-macroglobulin therapies and drug screening methods for Alzheimer's disease |
| 08/22/2002 | US20020114791 Dehydration; freeze-drying; removing alcohol (sterol or cholesterol); loading with oligosaccharides to preserve; storage stability |
| 08/22/2002 | US20020114789 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 08/22/2002 | US20020114788 Cell implantation therapy for neurological diseases or disorders |
| 08/22/2002 | US20020114786 Pharmaceutical preparations comprising soybean isoflavone extracts and probiotic microogranisms |
| 08/22/2002 | US20020114783 Human gene therapy for inherited or acquired proliferative ocular disease; transduction of mitotically active and inactive cells |
| 08/22/2002 | US20020114772 Methods of modulating hair growth |
| 08/22/2002 | DE10104584A1 Medane-Gene und- Proteine Medane genes and- proteins |
| 08/22/2002 | CA2856986A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2440743A1 Matrix gene expression in chondrogenesis |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438153A1 Post-partum mammalian placenta, its use and placental stem cells therefrom |
| 08/22/2002 | CA2438125A1 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 08/22/2002 | CA2437957A1 Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
| 08/22/2002 | CA2433936A1 Localized myocardial injection method for treating ischemic myocardium |
| 08/21/2002 | EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/21/2002 | EP1233058A1 Method of proliferating natural killer cells |
| 08/21/2002 | EP1232264A2 Human fgf-21 gene and gene expression products |
| 08/21/2002 | EP1232203A1 3d matrix for producing cell transplants |
| 08/21/2002 | EP1232170A1 Antimitotic compounds |
| 08/21/2002 | EP1231941A1 Tablets comprising micro-organisms and method for preparation of the tablets |
| 08/21/2002 | EP1231927A2 Nontoxic vernix compositions and method of producing |
| 08/21/2002 | EP1231840A1 Anti-angiogenic cellular agent for cancer therapy |
| 08/21/2002 | EP1154801A4 Integration of transplanted neural progenitor cells into neural tissue of immature and mature dystrophic recipients |
| 08/21/2002 | EP0983075B1 A method to increase the survival of transplanted cells |
| 08/21/2002 | EP0929308B1 Pharmaceutical composition containing an embryonic extract as an active substance and relative preparation process |
| 08/21/2002 | EP0767670B1 Putamen ovi |
| 08/21/2002 | EP0752882B1 Treatment for diabetes |
| 08/21/2002 | CN1365284A Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 08/21/2002 | CN1364874A Stem and ancestral cell suspension for embryo hematogenesis and its preparing method and use |
| 08/21/2002 | CN1364642A Medicament for curing rhinitis |
| 08/21/2002 | CN1364628A Compound traditional Chinese dmedicine preparation-Manxiening pill for curing chronic diarrhea |
| 08/21/2002 | CN1364627A Medicine for curing cervical spondylopathy and vertebrae lumbales diseases |
| 08/21/2002 | CN1364621A Medicinal wine for curing rheumatism, rheumatoid and various diseases caused by wind and cold |
| 08/21/2002 | CN1364610A Blood sugar reducing tea |
| 08/21/2002 | CN1364609A External use medicine bag for stagnation-syndrome |
| 08/21/2002 | CN1364589A Medicine for curing carcinoma of stomach |
| 08/21/2002 | CN1364467A Antiphlogistic liquid |
| 08/21/2002 | CN1364466A Hemorrhoidal powder |
| 08/21/2002 | CN1089248C Medicine for curing diseases in nerve system and its preparing method |
| 08/21/2002 | CN1089246C Medicament for treating urinary calculus and its preparation method |
| 08/21/2002 | CN1089244C Chinese patent medicine for treating cancers and unknown toxic swellings (subcutaneous ulcer and carbuncle) and its preparing process |
| 08/21/2002 | CN1089242C Method for extracting active component of sea cock roach |
| 08/21/2002 | CN1089241C Bloody clam or big clam extract with anticancer function |
| 08/21/2002 | CN1089240C Sucking dog capsule and its production process |
| 08/20/2002 | US6437018 Malleable paste with high molecular weight buffered carrier for filling bone defects |
| 08/20/2002 | US6436907 Adenovirus-medicated gene transfer to cardiac and vascular smooth muscle |
| 08/20/2002 | US6436901 Composition comprising hirudin, potassium phosphate and sugar, prepared by forming isotonic solution of hirudin, dipotassium hydrogen phosphate, and selected sugar at specified hirudin concentration and freeze drying solution |
| 08/20/2002 | US6436899 Nutritional intervention composition for enhancing and extending satiety |
| 08/20/2002 | US6436704 Cell differentiation into acinar, ductal, and islet cells; immunogens; bioassays |
| 08/20/2002 | US6436693 Using dna helper virus vector dna mutated so that cis-acting signal sequences for packaging of dna are non-functional; helper virus dna may provide information necessary for production of viral particles but may not be packaged therein |
| 08/20/2002 | US6436447 Evacuant |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436404 Antitumor |